Therapeutic applications of tigecycline in the management of complicated skin and skin structure infections (Q36866216)

16 August 2017

1 reference

title

Therapeutic applications of tigecycline in the management of complicated skin and skin structure infections (English)

1 reference

16 August 2017

author name string

David Charles Grolman

series ordinal

1

1 reference

16 August 2017

publication date

1 May 2007

1 reference

International Journal of Infectious Diseases

16 August 2017

published in

1 reference

16 August 2017

volume

11 Suppl 1

1 reference

16 August 2017

page(s)

S7-15

1 reference

Medicare coverage of outpatient ambulatory intravenous antibiotic therapy: a program that pays for itself

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960002-2

7 January 2021

The management of skin and soft tissue infections: outpatient parenteral antibiotic therapy in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960002-2

7 January 2021

Dermatologic infections in the immunocompromised (non-HIV) host

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960002-2

7 January 2021

Use of in vitro susceptibility and pathogen prevalence data to model the expected clinical success rates of tigecycline and other commonly used antimicrobials for empirical treatment of complicated skin and skin-structure infections

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960002-2

7 January 2021

Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960002-2

7 January 2021

Prevalence and risk factors for carriage of methicillin-resistant Staphylococcus aureus at admission to the intensive care unit: results of a multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960002-2

7 January 2021

Diagnosis and treatment of diabetic foot infections

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960002-2

7 January 2021

Safety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double-blind phase 3 comparison study with vancomycin-aztreonam

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960002-2

7 January 2021

Geographic variations in garenoxacin (BMS284756) activity tested against pathogens associated with skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (2000).

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960002-2

7 January 2021

Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960002-2

7 January 2021

Surgical site infection (SSI) rates in the United States, 1992-1998: the National Nosocomial Infections Surveillance System basic SSI risk index

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960002-2

7 January 2021

Empiric therapy of bacterial infections in patients with severe neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960002-2

7 January 2021

Practice guidelines for the diagnosis and management of skin and soft-tissue infections

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960002-2

7 January 2021

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960002-2

7 January 2021

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960002-2

7 January 2021

International Conference for the Development of Consensus on the Diagnosis and Treatment of Ventilator-associated Pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960002-2

7 January 2021

Preventing Antimicrobial-Resistant Bacterial Infections in Surgical Patients

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960002-2

7 January 2021

Antimicrobial management strategies for Gram-positive bacterial resistance in the intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960002-2

7 January 2021

Of Pseudomonas, porins, pumps and carbapenems.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960002-2

7 January 2021

The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960002-2

7 January 2021

Acquisition of multidrug-resistant Pseudomonas aeruginosa in patients in intensive care units: role of antibiotics with antipseudomonal activity

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960002-2

7 January 2021

Ertapenem, the first of a new group of carbapenems

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960002-2

7 January 2021

Antimicrobial resistance: factors and outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960002-2

7 January 2021

Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960002-2

7 January 2021

“Collateral Damage” from Cephalosporin or Quinolone Antibiotic Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960002-2

7 January 2021

Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 2000)

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960002-2

7 January 2021

Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960002-2

7 January 2021

Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960002-2

7 January 2021

Management of fever in patients with cancer and treatment-induced neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960002-2

7 January 2021

Activity of GAR-936 and other antimicrobial agents against North American isolates of Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960002-2

7 January 2021

In vitro evaluation of tigecycline and comparative agents in 3049 clinical isolates: 2001 to 2002.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960002-2

7 January 2021

In vitro activity of tigecycline against isolates from patients enrolled in phase 3 clinical trials of treatment for complicated skin and skin-structure infections and complicated intra-abdominal infections

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960002-2

7 January 2021

Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002).

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960002-2

7 January 2021

Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surve

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960002-2

7 January 2021

Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960002-2

7 January 2021

Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001-2002: the BSAC Bacteraemia Resistance Surveillance Programme

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960002-2

7 January 2021

Skin and soft tissue infections in Latin American medical centers: four-year assessment of the pathogen frequency and antimicrobial susceptibility patterns

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960002-2

7 January 2021

Diagnostic PCR analysis of the occurrence of methicillin and tetracycline resistance genes among Staphylococcus aureus isolates from phase 3 clinical trials of tigecycline for complicated skin and skin structure infections

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960002-2

7 January 2021

Results of a multicenter, randomized, open-label efficacy and safety study of two doses of tigecycline for complicated skin and skin-structure infections in hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960002-2

7 January 2021

Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections: Results from a phase 3, randomized, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960002-2

7 January 2021

10.1016/S1201-9712(07)60002-2

Identifiers

DOI

1 reference

16 August 2017

1 reference